Expert Views on the Management of Diabetic Retinopathy and Retinal Vein Occlusion
Diabetic retinopathy and retinal venous occlusions, including central retinal vein occlusions (CRVO) and branch retinal vein occlusions (BRVO), are the most common retinal vascular disorders. Diabetic retinopathy is a major cause of blindness and low vision, and diabetic macular edema (DME) is the leading cause of functional vision loss in persons with diabetes.

Upon completion of this activity, participants should be able to explain the pathophysiology of DME, CRVO, and RVO; describe the evidence supporting vascular endothelial growth factor and anti-inflammatory agents as therapeutic targets; explain the standards of care for DME, CRVO, and RVO; compare available monotherapies and combination therapies for DME and RVO; discuss the current clinical evidence for treatments for DME and RVO, including treatments not shown to be effective; and discuss ongoing studies of treatment for DME and RVO. » Go to this activity

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.